Wednesday, 3 December 2014
COSA Breakfast session – Cancer specific advance care planning – Considering challenges and opportunities |
---|
7:15 AM–8:45 AM Meeting Room 212 & 213 |
Facilitated by A/Prof Natasha Michael Speakers include: A/Prof Natasha Michael, Director of Palliative Medicine, Cabrini Health A/Prof Clare O'Callaghan, Sr Research Associate, Cabrini Health Ms Angela Baird, Clinical Nurse Coordinator, Cabrini Health |
This symposium will draw from Phase 1 and Phase 2 research conducted at a metropolitan cancer centre. Using the vignette technique and mixed method research, it involved close to one hundred cancer patients and their caregivers to understand and develop a cancer specific ACP intervention. It will highlight the need for a patient and family-centered approach to ACP and include recommendations from involved participants on future models of implementation.
Using experiential data, we will specifically discuss complexities related to the iterative process of decision making that evolves in cancer patients and the need for professionals working in cancer care to be attuned to the widely varied reactions they may encounter. We will also critically appraise the use of the vignette technique as a communication approach to facilitate difficult ACP conversations.
COSA Breakfast session – Nursing and cancer survivorship: A perfect match |
---|
7:15 AM–8:45 AM Meeting Room 216 |
Facilitated by COSA ASM keynote speaker, Mary McCabe and Priscilla Gates |
Since the Institute of Medicine published the seminal report, “From Cancer Patient to Cancer Survivor: Lost in Transition” in 2005, tremendous strides have been made in developing models of care with attention to the services needed by this growing population. Key to the development and implementation of these clinical care models is the profession of nursing. This session will include a presentation of the unique and important roles for nurses. The range of services – from psychosocial counselling services to comprehensive independent practices- that are being instituted by nurses will be discussed with attention to the variety of care settings across countries. The session will include time to share and compare nursing roles in survivorship care between the United States and Australia.
Breakfast session – PoCoG Early career mentoring breakfast |
---|
7:15 AM–8:45 AM Meeting Room 220 |
Facilitated by PoCoG ECR members, Sheleigh Lawler, Danette Langbecker, Amanda Hutchinson |
On behalf of Australia's Psycho-oncology Co-operative Early Career Research Group we would like to invite you to a special breakfast. Our vision for this event is to provide early career researchers working in psycho-oncology and related areas with an opportunity to have a highly interactive question and answer session with speakers who will address developing your research profile using social media, career progression and being competitive for grants and fellowships. Come prepared with your questions. As early career researchers we all face high levels of competition whether it be for securing employment, or gaining that first grant as chief investigator.
Breakfast session – VOYCE (YERVOY Clinical Network): Supporting medical oncologists and nurses in managing patients on YERVOY treatment |
---|
7:15 AM–8:45 AM Meeting Room 219 |
VOYCE (YerVOY Clinical nEtwork) is a clinical network and educational program designed to support medical oncologists and nurses in the safe and appropriate use of YERVOY® (ipilimumab). The cornerstone of VOYCE is peer-to-peer connectivity, and components include peer advisors, case-studies, and preceptorships. This session will explain how VOYCE may benefit both medical oncologists and nurses in their management of patients with metastatic melanoma on YERVOY treatment. Exploring the important collaborative relationship between the medical oncologist and nurse, representative experienced speakers will present case-studies demonstrating their concerted approaches to managing patients on YERVOY treatment. Attendees will have the opportunity to participate in interactive case-studies to learn about the efficacy and safety considerations of YERVOY. Join the conversation with VOYCE at COSA ASM 2014!
Plenary – Recent improvements in lung cancer care: What you must know | |
---|---|
9:00 AM–10:30 AM Plenary Hall 3 |
|
Chair: Matthew Peters | |
9:00 AM Matthew Peters | |
Lung cancer globally: Where are we? abs#69 | |
9:10 AM Thomas Lynch | |
Targeted therapy for NSCLC 2015: Second gen, third gen and beyond abs#70 | |
9:30 AM Harvey Pass | |
Surgery for lung cancer 2014: CT nodule stratification and management abs#71 | |
9:50 AM David Ball | |
Radiotherapy for lung cancer: Getting personal abs#72 | |
10:10 AM Thomas Jagoe | |
New perspectives on symptom management during treatment for advanced lung cancer abs#73 |
Morning tea and Poster viewing |
---|
10:30 AM–11:00 AM Trade Exhibition Hall |
Concurrent session – The best ways of controlling lung cancer | |
---|---|
11:00 AM–12:30 PM Plenary Hall 3 |
|
Chair: Ian Olver | |
11:00 AM Ian Olver | |
Lung cancer: Butt out or screen? abs#74 | |
11:20 AM Mary Assunta | |
The WHO FCTC: An international tool for tobacco control abs#75 | |
11:40 AM Sumitra Thongprasert | |
Oncologist and tobacco abs#76 | |
12:00 PM Freddy Sitas | |
Quit smoking after cancer diagnosis abs#77 |
Concurrent session – Emerging technologies | |
---|---|
11:00 AM–12:30 PM Meeting Room 212 & 213 Chair: Robin Anderson |
|
11:00 AM Jeffrey Crosbie | |
Physical and biological approaches to measuring the dose distribution in synchrotron microbeam radiation therapy abs#78 | |
11:15 AM Peter Rogers | |
Biological response of tumours and normal tissues to synchrotron microbeam radiation therapy (MRT) abs#79 | |
11:30 AM Matt Trau | |
Tunable nano-shearing: Some New Ideas for Capturing CTCs and rare molecules from blood abs#80 | |
11:45 AM Sasha Senthi | |
Can we improve clinical outcomes using stereotactic radiotherapy for oligometastatic disease? abs#81 | |
12:00 PM Harvey Pass | |
Biomarker studies in lung cancer and mesothelioma abs#82 |
Concurrent session – Symptom management in lung cancer | |
---|---|
11:00 AM–12:30 PM Meeting Room 219 |
|
Chair: Natasha Michael | |
11:00 AM Dorothy Keefe | |
Mucositis and its links to other toxicities in lung cancer abs#83 | |
11:20 AM Irene Higginson | |
Recent advances in the epidemiology, assessment and management of refractory breathlessness in lung cancer abs#84 | |
11:40 AM Thomas Jagoe | |
Exercise in the management of fatigue in lung cancer abs#85 | |
12:00 PM Melanie Lovell | |
Cancer pain: Closing the evidence-practice gap abs#86 |
Submitted symposia – Online psychological interventions to improve cancer care | |
---|---|
11:00 AM–12:30 PM Meeting Room 220 Chair: Addie Wootten |
|
Access to appropriate and timely psychosocial care can be challenging for many people diagnosed with cancer, particularly for those living in rural or regional locations1. There is growing interest in delivery of clinical services using internet enabled technology, particularly the delivery of psychological interventions online2. This symposium aims to explore the growing body of research investigating the feasibility, acceptability and efficacy of delivering online psychological interventions in the context of cancer care. This symposium will explore the challenges and benefits of delivering psychological interventions online through the presentation of five different online psychological interventions across different patient groups. | |
11:00 AM Addie Wootten | |
My road ahead: Results from an RCT evaluating an online psychological support program for men with prostate cancer abs#87 | |
11:18 AM Louise Heiniger | |
e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer abs#88 | |
11:36 AM Jo-Anne Abbott | |
Developing an online psychological support intervention for partners of men with prostate cancer abs#89 | |
11:54 AM Emma Kemp | |
Finding my way: Preliminary findings from a RCT evaluating an internet self-help program for cancer-related distress abs#90 | |
12:12 PM Catalina Lawsin | |
Improving reach and uptake of psychosexual support: Introducing Rekindle, a web-based psychosexual resource for all cancer survivors and their partners abs#91 |
Best of the Best Orals – Clinical | |
---|---|
11:00 AM–12:30 PM Meeting Room 216 Chair: Ian Davis |
|
Discussant: Normand Laperriere | |
11:00 AM David Chan | |
Impact of chemotherapy partner on efficacy of targeted agents in metastatic colorectal cancer (mCRC): Systematic review and meta-analysis abs#92 | |
11:15 AM Matthew Chan | |
An updated meta-analysis of taxanes for metastatic breast cancer: 10 years on abs#93 | |
11:30 AM Richard De Boer | |
Risk factors for hypocalcaemia in patients with cancer receiving denosumab abs#94 | |
11:45 AM Roopa Lakhanpal | |
Predictive value of immunohistochemical 4 plus clinical treatment score in determining risk of loco regional recurrence in early breast cancer abs#95 | |
12:00 PM Jia Jenny Liu | |
Retrospective comparison of rectal cancer treatment in China and Australia from 1995–2012 abs#96 | |
12:15 PM Rebecca Tay | |
Survival outcomes following adjuvant fluoropyrimidine-containing chemotherapy for resected early stage rectal adenocarcinoma abs#97 |
Best of the Best Orals – Education | |
---|---|
11:00 AM–12:30 PM Meeting Room 218 |
|
Chair: Alan Coates Discussant: Donna Milne |
|
11:00 AM Alana Fisher | |
“Not just following what doctors say”: Piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 (SNAC2) trial abs#98 | |
11:15 AM Yada Kanjanapan | |
Learning through clinical trials: 2013 and 2014 Preceptorship in colorectal cancer (CRC) – an initiative of the Australasian Gastro-Intestinal Trials Group (AGITG) abs#99 | |
11:30 AM Clare O'Callaghan | |
Men's and partners' reactions to localised prostate cancer: Medical and community education on treatment options is needed abs#100 | |
11:45 AM Gail Rowan | |
Potential interactions and issues associated with the use of CAM commonly used in the cancer population abs#101 | |
12:00 AM Samantha Van Staalduinen | |
An innovative approach to online learning in adolescent and young adult (AYA) cancer care abs#102 | |
12:15 AM Lisa Whop | |
Are Indigenous cancer patients treated according to clinical guidelines? abs#103 |
Lunch |
---|
12:30 PM–1:30 PM Trade Exhibition Hall |
COSA AGM 12:30 PM–1:30 PM Room 212/213 |
Plenary – What factors influence patient outcomes? | |
---|---|
1:30 PM–3:00 PM Plenary Hall 3 |
|
Chair: Meinir Krishnasamy | |
1:30 PM Jon Emery | |
Timely diagnosis of lung cancer abs#104 | |
1:50 PM Sarah Everitt | |
Functional imaging: Predicting patient outcomes during chemo-radiation therapy for NSCLC? abs# 105 | |
2:10 PM Julia Downing | |
What factors influence patient outcomes: Early referral to palliative care abs#106 | |
2:30 PM Zoe Wainer | |
The inequity of being male; sex differences in prognostic outcomes for patients with cancer abs#107 |
Afternoon tea |
---|
3:00 PM–4:00 PM Trade Exhibition Hall |
Poster discussion 2 (see separate listings) | |
---|---|
3:00 PM–4:00 PM Trade Exhibition Hall |
|
Best of the Best Poster discussion A – Epidemiology and Health services | |
3:15 PM–3:40 PM Trade Exhibition Hall – Theatrette 1 Chair: Dianne O'Connell Discussant: Paul Katris |
|
3:15 PM Pawan Bajaj | |
A review of the epidemiology, pathology, treatment and outcomes in patients with Head and Neck cancer with focus on Oropharyngeal squamous cell carcinoma ( OPSCC) presented at Gold Coast University Hospital from 2011–2012 abs#351 | |
3:20 PM Louisa Flander | |
Genetic test declining and high cancer risk perception in DNA mismatch repair gene mutation families abs#352 | |
3:25 PM Kate McBride | |
An International Survey of Awareness of Genetic Risk in the Adult and Paediatric Clinical Sarcoma Community abs#353 | |
3:30 PM Mihitha Ariyapperuma | |
Outcomes of medical oncology patients admitted to ICU/HDU compared to non-cancer patients in a tertiary care centre abs#354 | |
3:35 PM Arti Thakerar | |
Pharmacist advice on the safety of Complementary and Alternative Medicines (CAM) during conventional anticancer treatment abs#355 |
Best of the Best Poster discussion B – Supporting Indigenous and poor prognosis cancer patients | |
---|---|
3:15 PM–3:40 PM Trade Exhibition Hall – Theatrette 2 Chair: Patsy Yates Discussant: Jane Turner |
|
3:15 PM Anna Collins | |
I-COPE: pilot testing an innovative model of supportive and palliative care for patients with high grade glioma and their carers abs#356 | |
3:20 PM Gail Garvey | |
Psychometric properties of an Australian Supportive Care Needs Assessment Tool for Indigenous People (SCNAT-IP) with cancer abs#358 | |
3:25 PM Barbara Page | |
An audit and evaluation of the lung cancer journey: metropolitan and non-metropolitan abs#359 | |
3:30 PM Belinda Thewes | |
Patient and clinician perceptions of the feasibility and utility of routine unmet needs screening for Indigenous Australians with cancer abs#360 |
Concurrent session – The lung cancer MDT |
---|
4:00 PM–5:30 PM Plenary Hall 3 Chair: Shane White |
Speakers:
This sessions follows a highly successful format used at previous meetings. It is designed to provide a forum for discussion of the complex issues which arise in the care of patients with lung cancer. The facilitator will present a series of challenging clinical cases and engage members of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience to contribute to the discussion. |
Concurrent session – Mesothelioma | |
---|---|
4:00 PM–5:30 PM Meeting Room 212 & 213 |
|
Chair: Nico van Zandwijk | |
4:00 PM Glen Reid | |
Repressed microRNA expression in MPM: Small genes, big impact abs#108 | |
4:22 PM Stephen Clarke | |
What's new in malignant mesothelioma? abs#109 | |
4:44 PM Y C Gary Lee | |
Malignant pleural effusion – best practice abs#110 | |
5:06 PM Jason Fowler | |
Mesothelioma from the patient's perspective: Quality of life and lived experience in people with MPM abs#111 |
Concurrent session – Nutrition | |
---|---|
4:00 PM–5:30 PM Meeting Room 219 |
|
Chair: Anna Boltong | |
4:00 PM Kathryn Marshall | |
Malnutrition in patients with lung cancer – results from the Victorian Cancer Services abs#112 | |
4:15 PM Thomas Jagoe | |
Science of cachexia abs#113 | |
4:35 PM Judy Bauer | |
Nutritional needs of people with mesothelioma abs#114 | |
4:50 PM Nicole Kiss | |
Identifying risk factors for malnutrition in lung cancer patients receiving radiotherapy abs#115 | |
5:05 PM Peter Martin | |
What we have learnt in running a dedicated cancer cachexia service abs#116 |
Submitted symposia – Contemporary issues in evidence based integrative oncology | |
---|---|
4:00 PM–5:30 PM Meeting Room 220 |
|
Chair: Paul Katris | |
4:00 PM Donald Abrams | |
Cannabis in cancer and palliative care abs#117 | |
4:20 PM Donald Abrams | |
Rational use of dietary supplements abs#118 | |
4:43 PM Lesley Braun | |
Health professional advice: COSA position statement abs#119 | |
5:06 PM Nikolajs Zeps | |
NHMRC Homeopathy Working Party abs#120 |
Best of the Best Orals – Epidemiology | |
---|---|
4:00 PM–5:30 PM Meeting Room 216 |
|
Chair: David Ellis | |
Discussant: TBC | |
4:00 PM Anne Cust | |
Impact of common genomic variants on melanoma risk prediction abs#121 | |
4:15 PM Fran Boyle | |
Half of women with early breast cancer stop endocrine therapy before five years: Results from an Australian population-based study abs#122 | |
4:30 PM Qingwei Luo | |
A population-based study of progression to metastatic prostate cancer in Australia abs#123 | |
4:45 PM Tai Hing Lam | |
Risk estimates of lung cancer in a Chinese population at a later stage of the tobacco epidemic: Guangzhou Biobank Cohort Study abs#124 | |
5:00 PM Rajah Supramaniam | |
Are Aboriginal people more likely to be diagnosed with advanced cancer? abs#125 | |
5:15 PM Xue Qin Yu | |
A population-based study of breast cancer prevalence in Australia: Predicting the future health care needs of women living with breast cancer abs#126 |
Best of the Best Orals – Supportive care | |
---|---|
4:00 PM–5:30 PM Meeting Room 218 |
|
Chair: Meinir KrishnasamyDiscussant: Julia Downing | |
4:00 PM Sarah Benge | |
Assessing the efficacy of ice-cream-formulated iron-saturated lactoferrin and anhydrous milk fat in preventing chemotherapy induced diarrhoea – the ReCharge Study, a randomised phase IIb trial abs#127 | |
4:15 PM Louise Heiniger | |
Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer abs#128 | |
4:30 PM Lisa Mackenzie | |
Radiation oncology outpatients' concern about, preferences for, and perceived barriers to discussing anxiety and depression abs#129 | |
4:45 PM Rachel Brebach | |
Uptake and adherence to psychological support for cancer patients: A meta-regression abs#130 | |
5:00 PM Kathryn Marshall | |
Addressing malnutrition in Victorian Cancer Services: Are we making a difference? abs#131 | |
5:15 PM Rob Sanson-Fisher | |
Life expectancy discussions in a multi-site sample of Australian medical oncology outpatients abs#132 |
Group meetings |
---|
5:30 PM–7:00 PM |
Conference dinner |
---|
7:00 PM pre-dinner drinks 7:30 PM to late |
Held in the Crown Palladium Room |